CDT1 and cancer: By applying an AlphaScreenTM HTS assay, we discovered a small molecule inhibitor of CDT1/Geminin protein complex, which facilitates effective targeting of cancer cells, thereby providing a promising lead compound that could serve as a chemical scaffold for further chemical optimization.